Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

R01 CA90759: The Effects of Lycopene on High Risk Prostatic Tissue

NCT01443026 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT01443026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01443026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
R01 CA90759: The Effects of Lycopene on High Risk Prostatic Tissue
Lead sponsor
University of Illinois at Chicago
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
April 30, 2009
Enrollment
66 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

intraepithelial prostatic neoplasia, prostatic neoplasms